Drugs / P-3074
last change Mar 2018 re-read 9 days ago

P-3074

Developed for
androgenetic alopecia
Investigated by
Polichem S.A.

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03004469 Aug 2016 → Mar 2018 androgenetic alopecia Polichem S.A. Completed Met primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as P-3074 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03004469 ↗
Route Topical “topical application of P-3074 contained finasteride 0.25% in morning onto dry scalp only (up to 4 puffs)” NCT03004469 ↗